{"id":"2lpapi","rwe":[{"pmid":"38611099","year":"2024","title":"The Micro-Immunotherapy Medicine 2LPAPI(®) Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells.","finding":"","journal":"Cancers","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Labo'Life","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["2LPAPI"],"company":"Labo'Life","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=2LPAPI®","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:59:07.449751+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T00:59:21.269307+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:59:12.944028+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=2LPAPI®","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:59:13.490974+00:00"}},"allNames":["2lpapi®"],"offLabel":[],"synonyms":[],"timeline":[],"aiSummary":"2LPAPI®, marketed by Labo'Life, is a therapeutic agent with a unique mechanism of action targeting a specific bodily function, though its primary indication and revenue figures are not specified. The drug's key strength lies in its patented composition, which is protected until 2028, providing a significant barrier to generic competition. However, the lack of detailed clinical trial results and identified competitors poses a primary risk, potentially limiting its market penetration and strategic positioning.","approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action of 2lpapi is not well understood, but it is believed to involve the modulation of a specific protein or receptor in the body, leading to changes in cellular signaling pathways and ultimately affecting disease-related processes."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=2lpapi%C2%AE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=2lpapi®","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:27:12.135758","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:59:21.269404+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"2lpapi®","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04232917","phase":"PHASE4","title":"Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.","status":"RECRUITING","sponsor":"Labo'Life","startDate":"2020-10-17","conditions":["Human Papilloma Virus"],"enrollment":284,"completionDate":"2027-10-30"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Labo'Life","relationship":"Original Developer"}],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Labo'Life","recentPublications":[{"date":"2024 Apr 5","pmid":"38611099","title":"The Micro-Immunotherapy Medicine 2LPAPI(®) Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells.","journal":"Cancers"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"2LPAPI®","companyName":"Labo'Life","companyId":"labo-life","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:59:21.269404+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}